These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30287)

  • 1. Withdrawal syndromes associated with antipsychotic drugs.
    Gardos G; Cole JO; Tarsy D
    Am J Psychiatry; 1978 Nov; 135(11):1321-4. PubMed ID: 30287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
    Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC
    Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of tardive dyskinesia: use of dopamine-depleting agents.
    Fahn S
    Clin Neuropharmacol; 1983 Jun; 6(2):151-8. PubMed ID: 6133619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia: side effect or not?
    Curran JP
    Am J Psychiatry; 1973 Apr; 130(4):406-10. PubMed ID: 4144163
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
    Hunt JI; Singh H; Simpson GM
    J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
    Stahl SM; Davis KL; Berger PA
    J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P
    Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
    [No Abstract]   [Full Text] [Related]  

  • 11. Molindone and haloperidol in tardive dyskinesia.
    Glazer WM; Hafez HM; Benarroche CL
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):4-7. PubMed ID: 2862139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenergic effects in tardive dyskinesia, akathisia and pseudoparkinsonism via the limbic system and basal ganglia.
    Wilbur R; Kulik FA; Kulik AV
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):849-64. PubMed ID: 2907387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia.
    Seeman P; Tinazzi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():178-83. PubMed ID: 23454261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Aug; 48(8):11-4. PubMed ID: 20669865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance antipsychotic therapy: is the cure worse than the disease?
    Gardos G; Cole JO
    Am J Psychiatry; 1976 Jan; 133(1):32-6. PubMed ID: 2021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing.
    Borison RL
    Clin Ther; 1996; 18(4):592-607; discussion 591. PubMed ID: 8879889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
    Fallon P; Dursun SM
    J Psychopharmacol; 2011 Jun; 25(6):755-62. PubMed ID: 20147573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.